About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials in Houston | 515 Studies

Clinical Trials Prostate CancerHouston

Prostate Cancer Clinical Trials in Houston

Find 515 clinical trials for prostate cancer near Houston, Texas. Connect with research centers in your area.

All Prostate Cancer trials nationwide All trials in Houston

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 101-120 of 515 trials

CompletedStudy to Evaluate the Safety and Tolerability of CC-94676 in Participants With Metastatic Castration-Resistant Prostate CancerThe purpose of this study is to assess the safety, tolerability and preliminary efficacy of CC-94676 in men with progressive metastatic castration resistant prostate cancer.NCT04428788·Stanford, California and 18 others Active not recruitingA Study of Chemoimmunotherapy for the Treatment of Men With Neuroendocrine or Aggressive Variant Metastatic Prostate CancerThe purpose of this study is to evaluate the safety and efficacy of a combination of nivolumab, ipilimumab, cabazitaxel and carboplatin in men with neuroendocrine prostate cancer…NCT04709276·New York, New York and 2 others

Prostate Cancer Trials in Other Cities

New York Los Angeles Chicago Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

RecruitingA First-in-human (FIH), Phase 1 Study of ML261, an Autologous Potency Enhanced Anti-DLL3 CAR T Cell Therapy, in Participants With R/R SCLC or Select NECs (SPECTRAL-1)This is a first-in-human (FIH), open-label, Phase 1 study designed to evaluate the safety, pharmacokinetics (PK), and preliminary efficacy of ML261, an autologous potency enhanced…NCT07488923·St Louis, Missouri and 5 others

RecruitingA Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate CancerThe purpose of this study is to find out whether treatment with pasritamig and docetaxel prolongs radiographic progression free survival (rPFS) (the length of time from start of…NCT07225946·Chandler, Arizona and 157 others

Active not recruitingStudy of Talazoparib With Enzalutamide in Men With DDR Gene Mutated mCSPCThe purpose of the study is to evaluate the safety and efficacy of talazoparib in combination with enzalutamide compared with placebo in combination with enzalutamide in…NCT04821622·Birmingham, Alabama and 312 others

WithdrawnProvenge Followed by Docetaxel in Castration-Resistant Prostate CancerThis clinical study will evaluate the role of combination therapy of Provenge followed by docetaxel for patients with metastatic castration-resistant prostate cancer (CRPC…NCT02793219·Houston, Texas

CompletedPDR001 Plus LAG525 for Patients With Advanced Solid and Hematologic MalignanciesThe purpose of this signal seeking study is to determine whether treatment with PDR001 and LAG525 demonstrates sufficient efficacy in advanced malignancies to warrant further…NCT03365791·San Francisco, California and 19 others

Active not recruitingMagnetic Resonance Whole Body Diffusion-Weighted Imaging in Finding Bone or Lymph Node Metastasis in Participants With High-Risk Prostate CancerThis trial studies how well magnetic resonance whole body diffusion-weighted imaging works in finding cancer that has spread to the bone or lymph nodes (metastasis) in…NCT03085043·Houston, Texas

Active not recruitingA Prospective Comparative Study of Outcomes With Proton and Photon Radiation in Prostate CancerThis study is a large, prospective, pragmatic, controlled comparison of patient-centric outcomes \[quality of life (QOL), toxicity, and disease control\] between parallel cohorts…NCT03561220·Birmingham, Alabama and 52 others

CompletedA Study of XmAb®20717 in Subjects With Selected Advanced Solid TumorsThis is a Phase 1, multiple dose, ascending dose escalation study to define a MTD/RD and regimen of XmAb20717, to describe safety and tolerability, to assess PK and…NCT03517488·Los Angeles, California and 16 others

RecruitingDose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid TumorsThis study is designed to characterize the safety, tolerability, and anti-tumor activity of MDX2001 in patients with advanced solid tumors.NCT06239194·Denver, Colorado and 5 others

CompletedStudy of TT-00420 (Tinengotinib) Tablet as Monotherapy and Combination Therapy in Patients With Advanced Solid TumorsThis is a Phase Ib/II, multicenter, open-label study to evaluate the safety and preliminary efficacy of TT-00420 tablet, as monotherapy or in combination regimens, in patients…NCT04742959·Duarte, California and 5 others

Active not recruitingWater Vapor Ablation for Localized Intermediate Risk Prostate CancerThe purpose of this study is to evaluate the safety and efficacy of the Vanquish Water Vapor Ablation Device ("Vanquish") in treating subjects with Gleason Grade Group 2 (GGG2)…NCT05683691·Phoenix, Arizona and 24 others

CompletedCancer Prevention and Treatment Demonstration for Ethnic and Racial MinoritiesThe goal of this behavioral research study is to improve the use of cancer prevention services, increase early detection, and treatment of cancer.NCT00453661·Houston, Texas

CompletedS1014 Abiraterone Acetate in Treating Patients With Prostate Cancer Who Have Undergone Initial Hormone TherapyRATIONALE: Androgens can cause the growth of prostate cancer cells. Antiandrogen drugs, such as abiraterone acetate, may lessen the amount of androgens made by the body.NCT01309672·Jonesboro, Arkansas and 204 others

Active not recruiting177Lu-PSMA-I&T for Metastatic Castration-Resistant Prostate CancerA Multi-Center, Open-Label, Randomized Phase 3 Trial Comparing the Safety and Efficacy of 177Lu-PSMA-I\&T versus Hormone Therapy in Patients with Metastatic Castration-Resistant…NCT05204927·Tucson, Arizona and 51 others

RecruitingCollecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer DetectionThis study collects blood and tissue samples from patients with cancer and without cancer to evaluate tests for early cancer detection.NCT05334069·Anchorage, Alaska and 746 others

Completed"REDUCE" - A Clinical Research Study To Reduce The Incidence Of Prostate Cancer In Men Who Are At Increased RiskThis 4-year study will compare how safe and effective an oral investigational medicine is (compared to placebo) in preventing the development of prostate cancer in men that are…NCT00056407·Birmingham, Alabama and 931 others

RecruitingPre-Surgical Tirzepatide-Assisted Weight Loss in Overweight and Obese Men With Intermediate Risk Prostate Cancer: A Pilot Feasibility StudyThe goal of this clinical research study is to determine how well a tirzepatide-assisted weight loss program works before a prostatectomy in patients with intermediate risk…NCT06759701·Houston, Texas

Active not recruitingAvelumab, Utomilumab, Anti-OX40 Antibody PF-04518600, and Radiation Therapy in Treating Patients With Advanced MalignanciesThis phase I/II trial studies the side effects of avelumab when given in different combinations with utomilumab, anti-OX40 antibody PF-04518600, and radiation therapy in treating…NCT03217747·Houston, Texas

PreviousPage 6 of 26Next

Other Conditions in Houston

Breast Cancer Lung Cancer Colorectal Cancer Melanoma Leukemia Lymphoma